Two Sigma Investments
BCAX

Two Sigma Investments’s Bicara Therapeutics BCAX Stock Holding History

Two Sigma Investments’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79M Sell
89,881
-8,600
-9% -$148K ﹤0.01% 2844
2025
Q4 		$1.66M Buy
98,481
+3,243
+3% +$55.4K ﹤0.01% 2581
2025
Q3 		$1.5M Sell
95,238
-39,219
-29% -$439K ﹤0.01% 2318
2025
Q2 		$1.25M Buy
134,457
+121,687
+953% +$1.45M ﹤0.01% 2122
2025
Q1 		$166K Buy
+12,770
New +$170K ﹤0.01% 2888
2024
Q4 		– Sell
-9,000
Closed -$229K – 3547
2024
Q3 		$229K Buy
+9,000
New +$230K ﹤0.01% 2768

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $112M AUM 91.52% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Two Sigma Investments's BCAX Position: Q1 2026 in Review

Two Sigma Investments reduced its Bicara Therapeutics (BCAX) stake by 8.7% in Q1 2026, selling an estimated $148K and leaving 89,881 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2844.

Two Sigma Investments first reported a position in BCAX in Q3 2024 and has held it in 6 quarters since. 146 funds tracked by Wall St. Rank hold BCAX as of Q1 2026.

  • Two Sigma Investments held 89,881 shares of Bicara Therapeutics worth $1.79M as of Q1 2026.
  • Two Sigma Investments sold 8,600 Bicara Therapeutics shares in Q1 2026, an estimated $148K.
  • Bicara Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2844 holding.
  • Two Sigma Investments first reported a position in Bicara Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 146 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.